Recruiting

iTEAR100

Sponsor:

Olympic Ophthalmics, Inc.

Code:

NCT05304650

Conditions

Dry Eye Syndromes

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

iTEAR100

Study Details

Brief summary:

A Usability Study of External Neuromodulation With iTEAR100 Generation 2. A study which evaluates user ability to train and access the iTEAR100 device in a telehealth environment.

Conditions

Dry Eye Syndromes

Study ID

NCT05304650

Start date

Mar 1, 2022

Status verified date

Mar, 2022

Completion date

Jun 15, 2022

Anticipated

Primary completion date

Apr 30, 2022

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria: Able to sign English language consent form and over age 18 and reside in the U.S.

-

Exclusion Criteria:

-

Study Design

Enrollment

100 participants

Anticipated

Allocation

Non randomized

Intervention Model

Single group

Primary purpose

Other

Interventions and Outcome Measures

Arms

other: iTEAR100 Therapy

Treatment Arm. Assessment of usability of generation 2 connected devices

Interventions

iTEAR100

Controlled Stimulation External Nasal Nerve to stimulate tear production

Primary outcome measure

  • Usability [ Time Frame: 30 days ]

Central Contacts and Locations

Central contacts

Michael Gertner

650-300-9340clinicaltrials@oo-med.com

Locations

Olympic Ophthalmics

Recruiting

Issaquah, Washington, United States, 98027

Contacts

Michael Gertner

650-283-9388mgertner@oo-med.com

More Information

Sponsor

Olympic Ophthalmics, Inc.

Last update posted

Mar 31, 2022

Last verified

Mar, 2022

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Olympic Ophthalmics, Inc. on 2022-03-31.